ABSTRACT We have analyzed the expression pattern of protocadherin-19, a member of the δ2-protocadherins, in the nervous system of developing zebrafish using in situ hybridization methods. mRNA encoding protocadherin-19 (Pcdh19) began to be expressed at about 12 hours post fertilization (hpf) showing a segmental expression pattern in the anterior 1/3 of the neural keel, with strong expression in the presumptive forebrain, cerebellum/rhombomere 1 and rhombomere 4. Pcdh19 expression in the posterior neural keel was continuous and confined to the midline region. By 24 hpf, Pcdh19 was expressed widely in the brain and spinal cord, with higher expression levels in the ventral telencephalon, dorsal and central thalamus, optic tectum, central tegmentum, cerebellum and dorsolateral regions of the hindbrain. As development proceeded, Pcdh19 expression domains became restricted to the dorsal and/or lateral regions of the central nervous system, and Pcdh19 expression was not detected in the spinal cord of two-and threeday old embryos. Pcdh19 was also expressed by the eye primordium, developing retina, lens and otic vesicle. Similar to its expression in the brain, Pcdh19 expression in the eye and ear was also spatially and temporally regulated.
Pcdh domains, the zebrafish CM1 and CM2 are more similar to those of Pcdh18 (δ2) than Pcdh1 (δ1) (data not shown). Zebrafish Pcdh19 has two isoforms, which are identical except that isoform 1 is slightly shorter (missing amino acids 755-826 in the cytoplasmic domain, Fig. 1 ) than isoform 2. The human PCDH19 also has two variants but they differ by only one amino acid, with variant 1 containing an extra serine at amino acid 847 in the protein.
Pcdh19 expression
Compared to our extensive knowledge of classical cadherins (e.g. cadherin-1 and cadherin-2, also known as E-and N-cadherins, respectively) expression and function, little is known about Pcdh19 expression and function in developing vertebrates, and to the best of our knowledge, there is no published report on Pcdh19 expression in nonmammalian vertebrates.
Using reverse transcriptase-polymerase chain reaction (RT-PCR) and whole mount in situ hybridization methods, we analyzed expression of Pcdh19 in embryonic zebrafish from 6 hours post fertilization (hpf) to 72 hpf. RT-PCR experiments showed that both Pcdh19 isoforms were expressed by embryos of 10 hpf to 72 hpf, with isoform 2 expression slightly stronger than isoform 1 in 18-22 hpf and 72 hpf embryos (Fig. 4A) . cRNA probes designed to detect both pcdh19 isoforms were used to perform whole mount in situ hybridization. There was no Pcdh19 expression found in young embryos of 6 hpf ( Fig. 4B ) and 9 hpf (data not shown). At 12-13 hpf, Pcdh19 expression was observed in the neural keel. In the anterior neural keel, Pcdh19 expressing domains in the presumptive forebrain and hindbrain were separated by regions with little or no Pcdh19 expression (Fig. 4 C,D) . The eye primordia also contained Pcdh19 (Fig. 4D) . To determine the relative positions of the Pcdh19 expression domains in the presumptive hindbrain, we performed double-labeling experiments using digoxigenin-labeled Pcdh19 cRNA probes coupled with fluoresceinlabeled pax2a (labeling the boundary of the mid-and hindbrains, Krauss et al. 1991) or krox20 (labeling the rhombomeres 3 and 5, Oxtoby and Jowett 1993) . The first Pcdh19 expression domain (indicated by an arrow) in the presumptive hindbrain was located immediately posterior to the boundary between the mid-and hindbrains (Fig. 4F) , while the second Pcdh19 expression domain (indicated by an arrowhead) in the presumptive hindbrain was located between the rhombomeres 3 and 5 labeled by the krox20 probe (Fig. 4 G,H) . Therefore, the first and second Pcdh19 expression domains in the presumptive hindbrain were likely situated in the presumptive cerebellum/ rhombomere 1 and rhombomere 4, respectively. Pcdh19 expression in the posterior neural keel was continuous, but appeared to be restricted to regions along the midline (indicated by two arrows in Fig. 4E ).
At 18 hpf, Pcdh19 was expressed in both the brain and spinal cord , with obvious regional differences in expression levels, judged by staining intensities, in the fore-and midbrains (Fig. 5B) . The ventral telencephalon, ventral diencephalon and tegmentum showed stronger Pcdh19 expression than the remaining regions of the fore-and midbrains. Similar to Pcdh19 expression in the younger embryos (Fig. 4) tween the cerebellum and optic tectum (arrowhead in Fig. 5B ). No regional difference in expression levels was detected in the hindbrain (Fig. 5C ), except there was a narrow region, between the cerebellum and the remaining hindbrain, with reduced Pcdh19 expression (arrow in Fig. 5 B,C). This region was likely derived from the region between the first Pcdh19 expression domain and rhombomere 3 in the presumptive hindbrain of younger embryos (Fig. 4 G,H ). In the spinal cord, Pcdh19 expression appeared to be stronger in the floor plate region (Fig. 5D ). In addition to the Sequence identity percentages for pairwise comparisons between the above five δ2-protocadherin sequences, a mouse protocadherin-18 sequence (MPcdh18), and two δ1-protocadherin sequences: human protocadherin-1 variant 2 and zebrafish protocadherin-1. Diagonal shaded boxes indicate sequence comparisons between the same sequences, and therefore, represent 100% identity. Sequence comparisons were performed using ClustalW2. Other abbreviations are the same as in Fig. 2 . Other abbreviations: ac, anterior commissure; c, cerebellum; di, diencephalon; fp, floor plate of the spinal cord; h, hindbrain; hc, hair cells; hd, hypochord; le, lens; nc, notochord; or, optic recess; ot, optic tectum; p, pineal organ; poc, postoptic commissure; sc, spinal cord; te, telencephalon; teg, tegmentum; tpc, tract of posterior commissure; tpoc, tract of postoptic commissure. The remaining abbreviations are the same as in Fig. 4 . Scale bars,100 μm for (A-M), and 50 μm for (N-P).
nervous tissue, Pcdh19 was also seen in the hypochord below the notochord near the tail (Fig. 5D) . Embryos of 24 hpf showed somewhat similar Pcdh19 expression patterns in the fore-and midbrains as 18 hpf embryos, except that the staining was stronger in the dorsal thalamus (ventroanteral to the optic tectum, and adjacent to the tract of the posterior commissure, indicated by an Fig. 5N ). Abbreviations are the same as in Fig.  5 . Scale bars, 100 μm. asterisk in Fig. 5F ) and optic tectum (Fig. 5F ) than 18 hpf embryos (Fig. 5B) . In the telencephalon, the Pcdh19 expressing domain was located anterodorsal to the optic recess (Fig. 5 F,G) . The stronger labeled regions in the telencephalon, central thalamus and tegmentum appeared to form a continuous thick bank viewing laterally (Fig. 5F ). The stripe of tissue between the posterior border of the optic tectum and the boundary of the mid-and hindbrains continued to show much reduced staining (Fig. 5 F,G, indicated by two opposing  arrows) . In the hindbrain, Pcdh19 expression was continuous from the cerebellum to the spinal cord, with stronger expression levels detected in the cerebellum and dorsolateral hindbrain (Fig. 5 H,N) . A band of tissue between the dorsolateral and the ventromedial hindbrain showed reduced staining (indicated by two opposing arrows in Fig. 5N ). In the anterior spinal cord, its dorsal 1/3 area was also more strongly labeled than the ventral spinal cord (Fig. 5O) , while in the mid-trunk and tail regions of the spinal cord, regional differences in the staining was not detected and the floor plate region continued to express Pcdh19 (Fig. 5P) . Pcdh19 was also expressed by the retina, lens (Fig. 5 J,M) , and otic vesicle (5L and N). The lens and peripheral retina (future retinal marginal zones) were more strongly labeled than the central retina (Fig. 5M) . Epithelial cells in the lateral otic vesicle and the hair cells were strongly labeled (Fig. 5N) .
Pcdh19 expression was reduced and regional differences in expression levels became more pronounced in some regions of the CNS in 36 hpf embryos (Fig. 6) . Stronger Pcdh19 staining continued to be observed in the dorsal and central thalamus (Fig. 6 B,E,F) , the cerebellum (Fig. 6 B,C) , and the dorsolateral regions of the hindbrain (Fig. 6 B,C,G,H) . In the telecephalon, stronger Pcdh19 expression was found in the lateral portion (Fig. 6D) . In the diencephalon, the strongly labeled Pcdh19 expression domains in the dorsal and central thalamus indicate the boundary between the optic tectum and tegmentum. Abbreviations: f, forebrain; gcl, retinal ganglion cell layer; inl, inner nuclear layer; m, midbrain; onl, outer nuclear layer. Other abbreviations are as in Fig. 4 . Scale bars, 100 μm.
had the appearance of two horizontal bands in cross sections (Fig.  6E, indicated by two asterisks) . In the midbrain, Pcdh19 expression was confined mainly to the optic tectum and dorsal tegmentum (Fig. 6F) . Again, the region between the posterior border of the optic tectum and the boundaries of mid-and hindbrains (arrowhead in Fig. 6B) , and the region between the dorsolateral and the ventromedial hindbrain (opposing arrows in Fig. 6 G,H) had less Pcdh19 expression than their neighboring areas. The dorsal spinal cord contained higher Pcdh19 expressing cells than the ventral spinal cord even in the mid-trunk region (Fig. 6I) . Pcdh19 expression in the retina and lens was reduced compared to 24 hpf embryos, except in the retinal marginal zones and the lens epithelial layer (Fig. 6 E,F) . Strong Pcdh19 expression continued in the lateral epithelial cells of the otic vesicle, but its expression was reduced in the hair cells (Fig. 6G) .
Generally speaking, Pcdh19 expression in 50 hpf embryos was similar to those of 72 hpf (Fig. 7) . Similar to the younger embryos, stronger Pcdh19 staining was seen in the dorsal thalamus and dorsal tegmentum (Fig. 7B ), optic tectum ( Fig. 7 B ,F,J), cerebellum ( Fig. 7 B,K) , and dorsolateral hindbrain (Fig. 7 D,H,K) , but Pcdh19 expression in the central thalamus, tegmentum and hindbrain was reduced compared to 24 and 36 hpf embryos. At 50 hpf, Pcdh19 expression in the telencephalon (Fig. 7C) was mainly in the lateral regions (similar to 36 hpf embryos, Fig. 6D ), but stronger expression became restricted to the dorsal telencephalon by 72 hpf (Fig.  7I) . The region between the posterior border of the optic tectum and the boundary of the mid-hindbrains continued to show reduced staining (Fig. 7F) , while Pcdh19 expression in the ventromedial hindbrain was greatly reduced (Fig. 7K ) compared to younger embryos (Figs. 5N and 6G ). Pcdh19 expression in the spinal cord was no longer detectable at both 50 hpf (Fig. 7D , data not shown for spinal cord sections) and 72 hpf (Fig. 7 H,M) . In the eye, Pcdh19 expression became mainly confined to the retinal ganglion cell layer, while there was no Pcdh19 expression in the lens (Fig. 7  C,G) . Pcdh19 expression in the otic vesicle became further reduced (Fig. 7K) .
Pcdh19 expression in the embryonic zebrafish is somewhat similar to that in embryonic mice (Gaitan and Bouchard, 2006) . In both species, early Pcdh19 expression is mainly confined to the nervous system. Pcdh19 is found in the telencephalon and diencephalon, in the spinal cord, in the developing retinal ganglion cell layer and lens. In adult rat brain, Pcdh19 was expressed in specific regions of the telencephalon, diencephalon, midbrain and hindbrain (Kim et al. 2007) . In addition to the neural tissue, Pcdh19 is also expressed by several other tissues in human (RT-PCR analysis, Wolverton and Lalande 2001) and mouse (Gaitan and Bouchard 2006) , including the heart and kidney. It remains to be determined if Pcdh19 is expressed by these tissues in larval and adult zebrafish.
Materials and Methods
Zebrafish embryos were obtained from in house breeding, and maintained as described in the Zebrafish Book (Westerfield 2005) . Embryos for whole mount in situ hybridization were raised in PTU (1-phenyl-2-thiourea, 0.003%) at 28.5 o C, staged in hours post fertilization, and fixed in phosphate buffered 4% paraformaldehyde.
Cloning of zebrafish Pcdh19
A TBlastn search using human PCDH19 protein sequence as a query resulted in a zebrafish genomic DNA sequence CR318607. A zebrafish Pcdh19 cDNA fragment was amplified by PCR from a zebrafish embryonic cDNA Uni-ZAP XR library (discontinued; Stratagene, La Jolla, CA) using primers (forward primer 0, 5'-CGTTAGTCATAGACCTGAACGCCACTGA CC -3, reverse primer 0, 5'-TTACTACCAAGCCACGATGACAGTCTGAGC -3') flanking a predicted zebrafish Pcdh19 coding region. The PCR product was cloned in the pCR-Blunt II-TOPO vector (Invitrogen, Carlsbad, CA). Sequences of the clones indicated 2 isoforms, Pcdh19 isoforms 1 and 2 (GenBank, accession number: AB 362378 and AB 362379, respectively, F. Kubota and T. Murakami). Analysis of the deduced amino acid sequences of these isoforms revealed that they lack the N-terminal 1/3 (from signal sequence to about half of EC3) of the proteins compared to other protocadherins. A BLAST search using the Pcdh19 isoform 2 sequence resulted in a zebrafish cDNA clone sequence (wu:fc83e05, GenBank accession number: BC129243, Strausberg et al.) that contains all the incomplete Pcdh19 isoform 2 sequence, plus most of the missing Nterminal sequence. Compared to other protocadherins including the mammalian Pcdh19 proteins, this zebrafish sequence (zebrafish protocadherin-19 isoform 2) appeared to be missing some of the signal sequence in the 5' region. Using primers designed according to genomic sequence of wu:fc83e05 (GenBank accession number: NW 001884478) and mRNA sequence of the wu:fc83e05 (forward primer 1, 5'-CGCGTGAAGACAGACATCAA-3', forward primer 2, 5'-TTCCAAGGACATGGATTTCG-3', 58 and 25 nucleotides, respectively, 5' to the starting codon of the published wu:fc83e05 sequence; reverse primer 1, 5'-AGTAGACCACCTCGCCATTG-3', corresponding to the nucleotides 748 to 767 of the wu:fc8305), and total RNAs from 24-70 hpf whole zebrafish embryos, we performed RT-PCR and obtained the missing signal sequence (Fig. 1) .
RT-PCR analysis of Pcdh19 expression in developing zebrafish
RT-PCR analysis of Pcdh19 isoforms temporal expression profiles was performed using Pcdh19 specific primers (forward primer 3, 5'-GCCTTGGGCTCTATTGCAGTCA-3'; reverse primer 2, 5'-AGCATAGTGCCCTCTCTGGA-3', corresponding to nucleotides 1284-1305 and 1855-1874, respectively, of zebrafish Pcdh19 isoform 2, GenBank accession number AB 362379). These primers amplified bands of 377 bp and 590 bp for Pcdh19 isoforms 1 and 2, respectively (Fig. 4A) . Zebrafish cdh1 transcripts (Liu et al. 2007 ) were used as the control for the RT-PCR experiments because cdh1 was shown to be strongly expressed by young zebrafish embryos (Babb et al. 2005) .
In situ hybridization and immunocytochemistry
For obtaining a Pcdh19 DNA fragment (corresponding to the nucleotides 43-985 of the incomplete zebrafish Pcdh19 isoforms 1 and 2) as a template for synthesizing cRNA probes, zebrafish Pcdh19 specific primers (forward primer 4, 5'-CAATGGCGAGGTGGTCTACT-3'; reverse primer 3, 5'-CAACTCCAGCGTTTTTAGGG-3'), and total RNA isolated from 20-50 hpf whole zebrafish embryos were used for RT-PCR. This cDNA fragment was cloned into the pCRII-TOPO vector (Invitrogen), and was verified by restriction mapping and a PCR experiment using a pair of Pcdh19 specific primers that were internal to the previous set of primers (forward primer 5, 5'-GCCCGAAATCAAACTGTTGT-3'; reverse primer 4, 5'-GCACCTCCGATTTGATGATT-3'). This experiment produced a cDNA fragment corresponding to the nucleotides 266-729 of the incomplete zebrafish Pcdh19 isoforms 1 and 2). The larger Pcdh19 cDNA fragment in the pCRII-TOPO vector was used as a template for the synthesis of digoxigenin-labeled zebrafish Pcdh19 RNA sense or antisense probes for in situ hybridization. Both Pcdh19 isoforms contained this cDNA fragment. cDNAs used to generate the fluorescein-labeled antisense pax2a and krox20 were provided by Drs. Pamela Raymond (University of Michigan) and Lisa Maves (Fred Hutchinson Cancer Research Center), respectively. Detailed procedures for the cRNA probe synthesis and whole mount in situ hybridization were described previously (Liu et al. 1999; Liu et al. 2007; Kubota et al. 2008) . There was no staining in zebrafish embryos from 24-50 hpf using the sense Pcdh19 probes (data not shown).
Anti-acetylated tubulin antibody (Sigma, St Louis, MO) was used at 1:3000. The secondary antibody (used at 1:250) was biotinylated antimouse IgG (Vector laboratories, Burlingame, CA). Whole-mount immunocytochemistry was carried out according to protocols described in the Zebrafish Book (Westerfield 2005) .
